Skip to main content
Explore URMC

URMC Logo

menu

Jeanne Holden-Wiltse, M.P.H., M.B.A.

Publications

Showing all 29 journal articles & 0 books available

Journal Articles

5/25/2017
Yang H, Holden-Wiltse J, Topham DJ, Treanor J. "Maximum Likelihood Estimation of Titer via a Power Family of Four-Parameter Logistic Model." Journal of biopharmaceutical statistics.. 2017 May 25; Epub 2017 May 25.

3/1/2017
Caserta MT, Qiu X, Tesini B, Wang L, Murphy A, Corbett A, Falsey AR, Holden-Wiltse J, Walsh EE. "Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants." The Journal of infectious diseases.. 2017 Mar 1; 215(5):750-756.

3/2017
Caserta MT, Yang H, Gill SR, Holden-Wiltse J, Pryhuber G. "Viral Respiratory Infections in Preterm Infants during and after Hospitalization." The Journal of pediatrics.. 2017 Mar 0; 182:53-58.e3. Epub 2016 Dec 30.

9/23/2016
Chu CY, Qiu X, Wang L, Bhattacharya S, Lofthus G, Corbett A, Holden-Wiltse J, Grier A, Tesini B, Gill SR, Falsey AR, Caserta MT, Walsh EE, Mariani TJ. "The Healthy Infant Nasal Transcriptome: A Benchmark Study." Scientific reports.. 2016 Sep 23; 6:33994. Epub 2016 Sep 23.

6/2016
DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ. "Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection." Immunology.. 2016 Jun 0; 148(2):160-73. Epub 2016 Mar 30.

2016
Yang H, Baker SF, González ME, Topham DJ, Martínez-Sobrido L, Zand M, Holden-Wiltse J, Wu H. "An improved method for estimating antibody titers in microneutralization assay using green fluorescent protein." Journal of biopharmaceutical statistics.. 2016 26(3):409-20. Epub 2015 May 26.

12/2015
Scheible KM, Emo J, Yang H, Holden-Wiltse J, Straw A, Huyck H, Misra S, Topham DJ, Ryan RM, Reynolds AM, Mariani TJ, Pryhuber GS. "Developmentally determined reduction in CD31 during gestation is associated with CD8+ T cell effector differentiation in preterm infants." Clinical immunology : the official journal of the Clinical Immunology Society.. 2015 Dec 0; 161(2):65-74. Epub 2015 Jul 29.

2014
Miao H, Sangster MY, Livingstone AM, Hilchey SP, Zhang L, Topham DJ, Mosmann TR, Holden-Wiltse J, Perelson AS, Wu H, Zand MS. "Modeling the dynamics and migratory pathways of virus-specific antibody-secreting cell populations in primary influenza infection." PloS one. 2014 9(8):e104781. Epub 2014 Aug 29.

2013
Yang H, Topham DJ, Holden-Wiltse J, Wu H. "Statistical estimation & inference of cell counts from ELISPOT limiting dilution assays." Journal of biopharmaceutical statistics.. 2013 23(4):921-36.

2013
Henn AD, Wu S, Qiu X, Ruda M, Stover M, Yang H, Liu Z, Welle SL, Holden-Wiltse J, Wu H, Zand MS. "High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature." Scientific reports.. 2013 3:2327.

2013
Zhang H, Holden-Wiltse J, Wang J, Liang H. "A strategy to model nonmonotonic dose-response curve and estimate IC50." PloS one. 2013 8(8):e69301. Epub 2013 Aug 01.

11/1/2011
Wu H, Kumar A, Miao H, Holden-Wiltse J, Mosmann TR, Livingstone AM, Belz GT, Perelson AS, Zand MS, Topham DJ. "Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors." The Journal of immunology : official journal of the American Association of Immunologists.. 2011 Nov 1; 187(9):4474-82. Epub 2011 Sep 23.

2011
Huang Y, Wu H, Holden-Wiltse J, Acosta EP. "A DYNAMIC BAYESIAN NONLINEAR MIXED-EFFECTS MODEL OF HIV RESPONSE INCORPORATING MEDICATION ADHERENCE, DRUG RESISTANCE AND COVARIATES()." The annals of applied statistics.. 2011 5(1):551-577.

11/2010
Dykes C, Wu H, Sims M, Holden-Wiltse J, Demeter LM. "Human immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays." Journal of clinical microbiology.. 2010 Nov 0; 48(11):4035-43. Epub 2010 Sep 08.

7/2010
Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, Mosmann TR, Perelson AS, Wu H, Topham DJ. "Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus." Journal of virology.. 2010 Jul 0; 84(13):6687-98. Epub 2010 Apr 21.

1/22/2010
Baer J, Santiago F, Yang H, Wu H, Jeanne-Holden-Wiltse , Treanor J, Topham DJ. "B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant." Vaccine.. 2010 Jan 22; 28(4):907-15. Epub 2009 Nov 21.

7/2009
Lee HY, Topham DJ, Park SY, Hollenbaugh J, Treanor J, Mosmann TR, Jin X, Ward B, Miao H, Holden-Wiltse J, Perelson AS, Zand M, Wu H. "Simulation and prediction of the adaptive immune response to influenza A virus infection." Journal of virology.. 2009 Jul 0; 83(14):7151-65. Epub 2009 May 13.

4/11/2007
Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M. "Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial." JAMA.. 2007 Apr 11; 297(14):1577-82.

3/30/2001
Jacobson JM, Hafner R, Remington J, Farthing C, Holden-Wiltse J, Bosler EM, Harris C, Jayaweera DT, Roque C, Luft BJ, . "Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS." AIDS.. 2001 Mar 30; 15(5):583-9.

3/2000
Demeter LM, Shafer RW, Meehan PM, Holden-Wiltse J, Fischl MA, Freimuth WW, Para MF, Reichman RC. "Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)." Antimicrobial agents and chemotherapy.. 2000 Mar 0; 44(3):794-7.

6/1999
Para MF, Meehan P, Holden-Wiltse J, Fischl M, Morse G, Shafer R, Demeter LM, Wood K, Nevin T, Virani-Ketter N, Freimuth WW. "ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team." Antimicrobial agents and chemotherapy.. 1999 Jun 0; 43(6):1373-8.

3/16/1999
Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J, Valentine FT. "Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258." Annals of internal medicine.. 1999 Mar 16; 130(6):510-4.

10/1/1998
Demeter LM, Meehan PM, Morse G, Fischl MA, Para M, Powderly W, Leedom J, Holden-Wiltse J, Greisberger C, Wood K, Timpone J, Wathen LK, Nevin T, Resnick L, Batts DH, Reichman RC. "Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1998 Oct 1; 19(2):135-44.

4/1998
Dezube BJ, Von Roenn JH, Holden-Wiltse J, Cheung TW, Remick SC, Cooley TP, Moore J, Sommadossi JP, Shriver SL, Suckow CW, Gill PS. "Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1998 Apr 0; 16(4):1444-9.

12/1/1997
Fischl MA, Richman DD, Saag M, Meng TC, Squires KE, Holden-Wiltse J, Meehan PM. "Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1997 Dec 1; 16(4):247-53.

5/1/1997
Fischl MA, Richman DD, Flexner C, Para MF, Haubrich R, Karim A, Yeramian P, Holden-Wiltse J, Meehan PM. "Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1997 May 1; 15(1):28-34.

11/1/1996
Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS. "A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1996 Nov 1; 13(3):235-46.

9/1992
Drewnowski A, Holden-Wiltse J. "Taste responses and food preferences in obese women: effects of weight cycling." International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.. 1992 Sep 0; 16(9):639-48.

6/1992
Drewnowski A, Kurth C, Holden-Wiltse J, Saari J. "Food preferences in human obesity: carbohydrates versus fats." Appetite.. 1992 Jun 0; 18(3):207-21.